ABCL-334 Long-Term Survival Projections of Loncastuximab Tesirine-Treated Patients in Relapsed or Refractory Diffuse Large B-Cell LymphomaMehdi Hamadani, Carmelo Carlo‐Stella, Christopher N. Graham et al.|Clinical Lymphoma Myeloma & Leukemia|2022Cited by 0
Poster: ABCL-334 Long-Term Survival Projections of Loncastuximab Tesirine-Treated Patients in Relapsed or Refractory Diffuse Large B-Cell LymphomaMehdi Hamadani, Carmelo Carlo‐Stella, Hannah Strat et al.|Clinical Lymphoma Myeloma & Leukemia|2022Cited by 0